Evidence map›Paper›PMID 41323960›Full record

ArticleNeuro-oncology advances

Trends of hospital-based reporting of intracranial neoplasms in Nigeria from 1960 to 2024: A systematic review and pooled analysis of literatures.

Kehinde Alare, Samson Adedeji Afolabi, Busayo Adetunji, Chukwunonso Emmanuel Chukwumaeze, Emmanuel Kolawole Oluwumi, Kehinde Abdulazeez Periola, Taiwo Omoniyo, Okikioluwa Odesanya, Precious Adedokun, Stephen Ishola Adedokun and 6 more

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kehinde AlareBowers Neurosurgical Frailty and Outcomes Data Science Lab, Sandy, Texas.ORCID https://orcid.org/0000-0002-3708-0927
Samson Adedeji AfolabiDepartment of Medicine, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.ORCID https://orcid.org/0000-0002-3577-0625
Busayo AdetunjiDepartment of Medicine, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.ORCID https://orcid.org/0000-0001-9434-6130
Chukwunonso Emmanuel ChukwumaezeDepartment of Medicine, University of Nigeria Teaching Hospital, Ituku Ozalla, Nigeria.ORCID https://orcid.org/0000-0002-4668-5231
Emmanuel Kolawole OluwumiDepartment of Medicine, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.ORCID https://orcid.org/0009-0009-3928-0082
Kehinde Abdulazeez PeriolaDepartment of Medicine, Federal Teaching Hospital, Ido-Ekiti, Nigeria.ORCID https://orcid.org/0000-0002-2485-4700
Taiwo OmoniyoDepartment of Medicine, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.ORCID https://orcid.org/0000-0002-0589-060X
Okikioluwa OdesanyaAll Saints University School of Medicine, Dominica.
Precious AdedokunDepartment of Surgery, LAUTECH Teaching Hospital, Ogbomoso, Nigeria.ORCID https://orcid.org/0009-0007-4859-8514
Stephen Ishola AdedokunDepartment of Surgery, LAUTECH Teaching Hospital, Ogbomoso, Nigeria.
Nenkimun Dirting BakwaDivision of Neurosurgery, Department of Surgery, Jos University Teaching Hospital, Jos, Plateau, Nigeria.ORCID https://orcid.org/0009-0004-0035-2070
Joshua OpanikeDepartment of Medicine, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.ORCID https://orcid.org/0000-0001-6575-5875
Eromo KokoghoDepartment of Medicine, Federal Teaching Hospital, Ido-Ekiti, Nigeria.ORCID https://orcid.org/0009-0000-0874-0191
Oladunjoye David OlaniyanDepartment of Surgery, LAUTECH Teaching Hospital, Ogbomoso, Nigeria.
Paul Ibukunoluwa OyediranDepartment of Medicine, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.ORCID https://orcid.org/0009-0005-8229-9935
James BalogunDepartment of Neurosurgery, University College Hospital, Ibadan, Nigeria.ORCID https://orcid.org/0000-0002-0737-5265

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intracranial neoplasms, encompassing benign and malignant tumors, remain a significant health concern worldwide. This review systematically examines hospital-based reports of intracranial neoplasms in Nigeria from 1960 to July 2024, highlighting their distribution, demographics, and temporal trends. Methods: Following PRISMA guidelines, studies published from 1960 onward were identified through PubMed, Google Scholar, and African Journals Online. Eligible studies reported incidence, prevalence, or demographic data of intracranial neoplasms in Nigeria. Extracted data were pooled for meta-analysis to estimate aggregated incidence and prevalence. Results: Forty-five studies comprising 3517 cases were included. Pooled extrapolated prevalence was 3.22 (95% CI: 1.66-5.22), while compounded 10 yearly incidence was 3.66 (95% CI: 1.67-6.32). Reported incidence increased from 2.18% (1960-1969) to 4.08% (2000-2009) and 4.84% (2010-2019). Gliomas, meningiomas, and pituitary adenomas were the most frequent tumors. Among adults, meningioma predominated, followed by glioma and pituitary adenoma, whereas in children, gliomas were most common, followed by medulloblastoma and craniopharyngioma. Male predominance was observed (male-to-female ratio 1.17:1), with peak cases in the fourth to sixth decades. Regionally, southern Nigeria (southeast and southwest) showed higher incidence, reflecting disparities in diagnostic capacity and reporting compared with the north. Conclusion: Reported intracranial neoplasms in Nigeria have increased over the decades, with a prevalence of 3.22 and distinct demographic and geographic patterns. Strengthening diagnostic infrastructure, improving reporting systems, and establishing a national registry are essential for better understanding and management.

Indexed as

brain tumorepidemiologyintracranial neoplasmsNigeriaprevalence

Identifiers

PMID41323960
PMCPMC12658747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.